genomic analysis of HD cases with a high content of SR cells showed unexpected results. Apart from one study," only a few cases with clonal rearrangements were rep~r t e d .~, " , '~ Even in five cases with abundant SR cells (> 25%) no clonal rearrangements were identified.I4
These observations prompted us to test whether cases with an elevated number of SR cells harbor a high amount of EBV DNA and whether they contain a high percentage of genomic rearrangements. We assessed this by Southern blotting analysis of Ig and TcR gene rearrangements on 52 Swiss cases of HD (including 17 cases with a high content of SR cells). We also determined semiquantitatively the amount of EBV DNA by PCR in the same samples. We found that EBV DNA was present in most diagnostic lymph nodes and that clonality as determined by Ig and TcRP gene rearrangements was absent in most cases. However, no positive correlation between the number of SR cells and either the quantity of EBV DNA or the frequency of Ig gene rearrangements could be established.
MATERIALS AND METHODS
Tissue selection. Snap frozen tissue samples from 95 diagnostic lymph node biopsies from patients with H D were collected and stored at -70°C over an 8-year period (1981-88) at the Institute of Pathology, University Hospital, Zurich, Switzerland. For this study we selected 33 cases with mention of numerous SR cells (including variants) in the original histologic report and analyzed them together with a further 17 randomly chosen cases. Two additional (selected) cases with numerous SR cells were contributed in 1989 by the Institute of Pathology, University Hospital, Lausanne, Switzerland. Cases of lymphocyte-predominant nodular type of HD were excluded from the analysis because they most probably represent nomHodgkin's DNA from snap-frozen tissue samples of 17 reactive lymph nodes (histologically 12 follicular and five diffuse hyperplasias) was also analyzed by PCR. The biopsy sites of these lymph nodes were: cervical (nine times), axillary (five times), submandibular, pectoral, and inguinal.
Diagnosis of HD was performed on 4-km lymph node sections stained with hematoxilin and eosin. Five cases were classified as lymphocyte predominant diffuse (LPD), 27 as nodular sclerosis (NS), and 20 as mixed cellularity (MC). The degree of infiltration was calculated as the mean of the total frequency of SR Histology. Fresh frozen tissue samples were not used before DNA extraction except two HD cases where immunohistochemical analysis had been performed. All glass and plastic ware for DNA extraction were autoclaved before use. Genomic DNA was purified" under sterile conditions and digested with suitable restriction enzymes (BamHI, BglII for JH probe; BamHI, BglII for CK probe; EcoRI for CA probe and AIVS probe; BamHI, EcoRI, Hind111 for TcRP probe). Molecular characterization of the probes for JH, CK, CA, and AIVS, and technical details of radiolabeling and Southern blotting have recently been published." The probe for the TcRP VDJC region was a 700-bp Pst I fragment of the TcRP chain isolated from the Jurkat PI clone'9 and inserted into pSP64.
The sensitivity of Southern blotting analysis for the detection of rearrangements was determined by a mixing experiment; DNA extracted from lymphocytes of a T-cell leukemia (TCL; CD2+, CD3', CD4+, CD8-; 98% purity as determined by cell sorting) with the genotype cpl rearranged/@, germline (first allele) and cpl deleted/cp, rearranged (second allele) was diluted in placental DNA (germline configuration of the TcRp complex). As few as 3% of the clonal TCL population were still detectable (Fig 1) .
DNA from 65 fresh frozen tissue samples (48 HD samples, 17 reactive lymph node samples) was analyzed." PCR with samples from HD and reactive lymph nodes was performed at the same time. To avoid contamination the reaction mixture was prepared with tips containing cotton wool in the upper part. All plastic ware was autoclaved before use. Thirty amplification cycles were routinely performed. For cases that did not exhibit specific amplification products after 30 cycles, a further 30 cycles were performed. Each PCR was run with 1 pg of genomic DNA (exceptions are mentioned). Technical aspects of PCR, gel preparation, and Sma I digestion of amplified products are reported in detail elsewhere?' The enzyme used was Ampli Taq (Perkin Elmer Cetus, Norwalk, CT). EBV specificity of the amplified products obtained with the BMRF 1 set of primers was confirmed by hybridization with a "P-endlabeled 21-bp internal probe extending from position 438 to 458 (5'-CAGGTCTGGCATCATAGC-TGT-3') of the BMRF 1 regi0n.2~ For this hybridization 10 KL of each amplification reaction was electrophoresed in a 3% NuSieve GTG agarose gel (FMC Bio Products, Rockland, ME), stained with ethidium bromide, and photographed. Southern transfer (25 mmol/L NaPO,, pH 6.5) was performed overnight using GeneScreen filters (Du Pont de Nemours, Dreieich, Germany). Prehybridization was performed for 2 hours followed by hybridization for 8 to 12 hours in a solution containing 6 x SSC, 50 mmol/L NaPO, (pH 6.5), 1 mmol/L EDTA (pH 8), 0.5% sodium dodecyl sulfate (SDS), 100 &mL salmon sperm DNA, 0.25% nonfat milk.
Concentration of the y"P-endlabeled internal probe was 4 x l@ cpm/mL hybridization solution.
Human fibroblast DNA and human placental DNA were used as negative controls with EBV primers. Positive controls for EBV were DNA from four human lymphoblastoid cell lines derived from cord blood lymphocytes infected with four different clinical EBV samples, genomic DNA from an affected lymph node in a person with florid EBV infection, and DNA from Namalwa and Raji cell lines.
The Burkitt's lymphoma cell line Namalwa was shown to produce neither episomes nor viruses, but to have intact EBV DNA integrated on chromosome 1.2," Recently it has been reported by Lawrence et aIx that two EBV genomes are closely integrated at a known site of the unique chromosome 1. Thus, a single Namalwa cell harbors two EBV copies. Therefore, detection of the EBV genome with the BMRF 1 set of primers (only one BMRF 1 copy per one EBV genome) should still be possible when the DNA equivalent of one Namalwa cell (about 10 pg) serves as a template. With as few as 10 pg of Namalwa DNA we could still demonstrate a specific amplification product by gel electrophoresis when 60 amplification cycles were performed. The same was true when 10 pg of Namalwa DNA were mixed with 1 wg of placental DNA. Moreover, increasing the amount of Namalwa DNA gradually by a factor of 10 yielded correspondingly more specific amplification product as determined by both gel electrophoresis and subsequent blotting followed by specific oligonucleotide hybridization (Fig 2) . In the HD cases positive for EBV DNA (with 1 Kg of template DNA), graduated dilution (factor of 10) of template DNA therefore allowed to determine the last dilution step still giving rise to a specific amplification product after 60 cycles of PCR with the BMRF 1 set of primers. Thus, this last positive dilution (theoretically corresponding to minimal two, maximal 19 EBV copies, practically to about 10' viral copies) allowed us to calculate approximately the number of EBV copies in the initial DNA sample (lo' multiplied by the appropriate dilution factor).
Internal oligonucleotide probe.
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Semiquantitative analysis of viral DNA by PCR.
RESULTS
The histologic type of HD and the degree of infiltration by SR cells of the 52 cases are shown in Table 1 . The 17 cases with a high content of SR cells were all classified as NS and MC types of HD. Figure 3 illustrates an MC type of HD with abundant SR and H cells.
In all samples clonal rearrangements were assessed by Southern blot hybridization with specific probes for the Ig and TcRP gene loci. In most cases including those with numerous SR cells, the genes coding for heavy and light chains remained in germline configuration (Fig 4) . Clonal rearrangements of the Ig heavy chain gene were detected in only one MC and two NS types, a rearrangement of the A gene in one case of the NS type of HD ( Table 2) . Three of the rearranged cases belonged to group C ( < l o % of infiltration), and only one case to group A (Fig 5) . When hybridized with the TcRP probe numerous cases showed a nearly complete disappearance of the 11.5-kb germline band of the Cp, complex in EcoRI digests. This diminished intensity of the EcoRI germline band was proven to be a marker of polyclonal T-cell activation by the absence of clonal bands in Hind111 or BamHI digests.
A search for EBV DNA was performed by PCR in 48 cases. The PCR with specific primers for the BamW region of the EBV genome identified viral DNA in 67% of diagnostic lymph node biopsies from patients with HD after 30 amplification cycles and in 79% after 60 amplification cycles (Table 3) . EBV DNA containing cases were evenly distributed to all histologic types of HD. EBV DNA was detected in the three clonally rearranged cases of group C but not in the one of group A. Thirty of the EBV DNA Table 1 containing cases identified with the BamW set of primers were further analyzed using the BMRF 1 and EcoRI D sets of primers. With the BMRF 1 set of primers all 30 cases showed a specific amplification product when 1 kg of genomic DNA was screened; 26 of these cases were further analyzed in a graduated dilution experiment (see Materials and Methods) to determine approximately the number of EBV copies. As shown in Table 4 there was no correlation between the amount of EBV copies and the degree of infiltration by SR cells. The authenticity of the amplification products was confirmed by specific oligonucleotide hybridization (Fig 6) . Using the EcoRI D set of primers, 26 cases (87%) showed the expected 593-bp amplification product. Sma I digestion of the amplified sequences showed an EBV DNA specific restriction site at position 215 in all 20 cases examined (Fig 7) . In the cases negative for EBV DNA, the presence of an inhibitor of PCR was excluded by successful amplification of sequences of a part of the HLA DQa gene (not shown). When analyzing a control series of 17 reactive lymph nodes with identical sets of EBV primers, viral DNA was identified in only 29% of the cases?'
DISCUSSION
The aim of the present study was to determine: (1) the percentage of HD cases harboring EBV DNA in diagnostic lymph node biopsies, the approximate quantity of viral genomes in the EBV positive cases, and the clinical relevance of these findings; (2) the frequency of clonal rearrangements of Ig and TcRp genes in relation to the degree of infiltration by SR cells; and (3) between clonal rearrangements and EBV DNA identification.
EBV DNA has been identified by Southern blot or slot-blot hybridization in about 13% to 29%6*8*9,27 and by the sensitive PCR methodology after 30 amplification cycles in 50%'" and 58%" of HD cases. However, in this study EBV DNA was detected in 38 (79%) diagnostic lymph node biopsies from 48 patients by PCR with specific primers for the BamW region of the EBV genome when 60 amplification cycles were performed. The viral origin of the amplified DNA template was further proven by application of the BMRF 1 set of primers followed by specific oligonucleotide hybridization and of the EcoRI D set of primers with demonstration of an Sma I restriction site at the correct location within the amplified sequences.
As shown by Saito et alP and confirmed by our results, the possibility of detecting EBV DNA by PCR is considerably higher when 60 amplification cycles are performed. Using the BMRF 1 set of primers (only one BMRF 1 sequence per one EBV genome) we were able to identify two EBV copies per 10' diploid human genomes when the amplification product was analyzed by gel electrophoresis and ethidium bromide staining. However, when PCR was stopped after 30 amplification cycles only samples with at least lo3 viral copies of input DNA produced an easily identifiable amplification product. Similarly, in an other PCR system" working with 30 amplification cycles and a ck/ Bam HI 12 - Table 2 BamW set of primers (the BamW sequence is about 10 times reiterated per one EBV genome), approximately lo3 viral genomes or lo4 BamW sequences were needed to produce a clearly identifiable amplification product. Thus, by extending the number of amplification cycles from 30 to 60 the sensitivity to detect EBV DNA by ethidium bromide staining increases by a factor of 1,000. This fact largely explains the higher percentage of EBV-positive cases in our series.
In addition, we performed a semiquantitative analysis of EBV DNA by PCR using an endpoint dilution method with Namalwa DNA as a standard. Because about 100 EBV DNA copies are estimated to be necessary for a positive signal within a single SR cell by in situ hybridization: one would expect cases with numerous SR cells to contain abundant (> lo5) viral genomes, provided that most of the EBV DNA originates from SR cells as suggested by the in situ hybridization studies of Herbst et al." These investigators localized the EBV genomes exclusively in SR and H cells. Our findings obtained with extracted DNA showed no positive correlation between the quantity of SR cell DNA and EBV DNA in a given sample; in the group A with numerous SR cells no EBV DNA was detected in two cases and only a few copies (< 10') in two further cases. On the other hand, two cases with only a few SR cells harbored abundant EBV DNA. Therefore, our findings suggest that several cases of H D are not etiologically associated with EBV and also that cells other than the putative tumor cells may be the source of a high amount of EBV DNA in HD samples. However, the detection of at least one viral copy per one cell in two cases of HD with many SR cells and the recent identification of an oligoclonal HD case exhibiting linear EBV DNAB is consistent with ongoing viral replication. We agree that in this group of cases EBV may represent an etiologic agent as supposed by in situ hybridization ~tudies.8.~ A further molecular analysis of the EBV genome in HD is also needed because deletion and rearrangement within the viral genome known to switch it from latency to replicationz9 might influence the clinical course of HD. The high percentage of EBV DNA containing HD cases is not an isolated finding. Diagnostic tissue specimens from prelymphomatous conditions such as angioimmunoblastic lymphadenopathy,2' lymphomatoid granulomatosis,3' and Sjogren's syndromeU harbor EBV DNA in more than 70% of cases as demonstrated by PCR. EBV DNA is also frequently identified in lymphoid thymic hyperplasia3' and also detected by PCR in about 30% of reactive lymph nodes."szl It is usually not detected in normal lymph nodesZZ and only rarely in blood lymphocytes of healthy control^^^*^^ These data show that the identification of EBV DNA per se in lymph nodes, though preferentially associated with prelymphomas, is a nonspecific finding also observed in clinical conditions like autoimmunity or infection.
The clinical behavior of HD, especially in advanced stages, and the characteristics of HD-derived cell linesss6 suggest a malignant clonal disorder. This view is supported by the observations made by Brinker et a1: who analyzed seven cases with relatively high numbers of SR cells before treatment and identified Ig gene rearrangements in only one of them. In one of these cases with initial germline configuration of the Ig genes and in two additional cases, postmortem material with tumorous infiltration by SR cells was available for rearrangement studies; Ig gene rearrangements were detected in all three cases. The different findings in early and late stages of HD were explained' either with an initially clonal population below the sensitivity of the Southern method or with the presence of oligoclonal SR populations prone to undergo outgrowth of one malignant clone. The impossibility to detect clonal rearrangements in seven of the eight heavily infiltrated cases in our series is an argument in favor of initially oligoclonal SR cell populations, for in these cases the amount of genomic DNA originating from the SR cells exceeded by far the quantity needed (3%) for Ig and TcR gene rearrangement detection by the Southern technique. A new approach to get samples with a high amount of SR cell DNA was developed by Sundeen et aI5: by Percoll gradient centrifugation cell fractions with up to 9% of SR cells were obtained from nonselected HD cases. Rearrangement studies performed on DNA extracts from five such SR cell-enriched fractions showed clonal bands of the Ig genes in three cases. Obviously the clonal rearrangements belonged to the SR cell component, for the lymphocyte populations of these cases were shown to retain their Ig genes in germline configuration. However, the remaining two cases containing DNA of 5% or 9% from SR cells were 593-I 
